IONS vs IP · rev $226.6M vs P/E 43, $26.62B cap
Ionis Pharmaceuticals Inc (IONS) versus International Paper (IP) — a side-by-side from cached financials, not a winner call.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
International Paper (IP) is a packaging & containers company listed on US.
Latest reported IONS revenue for 2024-12-31 was $226.6M. Net income was -$104.3M. Revenue was down 30.2% from 2023-12-31 to 2024-12-31. IONS currently screens at market cap $12.28B.
IP does not have a complete income-statement cache yet.
IONS currently screens at market cap $12.28B. IP currently screens at market cap $26.62B and trailing P/E 43.1.
Not investment advice. Open the IONS and IP stock pages for the full models.
Not investment advice.